Resiquimod

產品活性：Resiquimod是一種Toll樣受體7和8 (TLR7/TLR8) 的激動劑， 誘導細胞因子如TNF-α，IL-6和IFN-α的上調。

研究領域：Immunology/Inflammation

作用靶點：Toll-like Receptor (TLR)

In Vitro: Resiquimod (R-848) induces both hapten- and allergen-specific circulating T cells, including TH2 effectors, to produce IFN-γ and even to lose the ability to produce IL-4. Resiquimod (R848) enhances PBL proliferation in a dose-dependent manner, and increases the number of BrdU-positive cells in BrdU incorporation assay. Cells treated with R848 exhibits significantly increased (3.5-fold) luciferase (a reporter of NF-κB activity) activity.

In Vivo: Resiquimod (R-848) (50 μg/bird, i.m. route) significantly up-regulates the expression of IFN-α, IFN-β, IFN-γ, IL-1β, IL-4, iNOS and MHC-II genes in SPF chicken.

相關產品：Drug Repurposing Compound Library  |  Clinical Compound Library  |  Clinical Compound Library Plus  |  Small Molecule Immuno-Oncology Compound Library  |  Drug Repurposing Compound Library Plus  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  Resatorvid  |  Chloroquine diphosphate  |  C29  |  Hydroxychloroquine sulfate  |  Imiquimod  |  Vesatolimod  |  Motolimod  |  CU-CPT22  |  Atractylenolide I  |  E6446 dihydrochloride  |  Paquinimod  |  TLR7/8 agonist 1 dihydrochloride  |  CU-CPT17e  |  Gardiquimod trifluoroacetate  |  Telratolimod  |  MD2-IN-1  |  Procyanidin B1  |  CU-CPT-8m  |  CU-CPT-9a  |  CU-CPT-9b  |  Toll-like receptor modulator  |  PF-4878691  |  AN-3485  |  IAXO-102  |  LHC-165  |  MMG-11  |  Neoseptin 3